In this review:
Never stop the sulfonylurea – just titrate it right down
Optimising diabetes diagnosis, prevention and care: is precision medicine the answer?
Prediabetes: does it really matter?
SGLT-2 inhibitors – mechanisms, additional benefits and outcome trials
SGLT-2 inhibitors – benefits on the kidney
Sending the right signals – how exercise keeps the rhythm in metabolism
GLP-1 receptor agonism: higher dose, combination therapy, or both
Going to bed with diabetes
Diabetes remission through insulin secretion by islet non-β cells
Retinopathy and AI
NAFLD & NASH – a reminder
Intraperitoneal insulin infusion – still alive and working
Please login below to download this issue (PDF)